Your browser doesn't support javascript.
loading
Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study.
Falchi, Lorenzo; Ma, Helen; Klein, Sandra; Lue, Jennifer K; Montanari, Francesca; Marchi, Enrica; Deng, Changchun; Kim, Hye A; Rada, Aishling; Jacob, Alice T; Kinahan, Cristina; Francescone, Mark M; Soderquist, Craig R; Park, David C; Bhagat, Govind; Nandakumar, Renu; Menezes, Daniel; Scotto, Luigi; Sokol, Lubomir; Shustov, Andrei R; O'Connor, Owen A.
Afiliação
  • Falchi L; Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY.
  • Ma H; Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY.
  • Klein S; Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY.
  • Lue JK; Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY.
  • Montanari F; Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY.
  • Marchi E; Division of Hematology and Oncology, Program for T-Cell Lymphoma Research, University of Virginia Cancer Center, Charlottesville, VA.
  • Deng C; Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY.
  • Kim HA; Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY.
  • Rada A; Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY.
  • Jacob AT; Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY.
  • Kinahan C; Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY.
  • Francescone MM; Department of Radiology.
  • Soderquist CR; Department of Pathology and Cell Biology, and.
  • Park DC; Department of Pathology and Cell Biology, and.
  • Bhagat G; Department of Pathology and Cell Biology, and.
  • Nandakumar R; Irving Institute for Clinical and Translational Research, Columbia University Irving Medical Center, New York, NY.
  • Menezes D; Translational Medicine (Hematology Oncology), Bristol Myers Squibb, San Francisco, CA.
  • Scotto L; Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY.
  • Sokol L; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL; and.
  • Shustov AR; Department of Medicine, University of Washington School of Medicine, Seattle, WA.
  • O'Connor OA; Division of Hematology and Oncology, Program for T-Cell Lymphoma Research, University of Virginia Cancer Center, Charlottesville, VA.
Blood ; 137(16): 2161-2170, 2021 04 22.
Article em En | MEDLINE | ID: mdl-33171487

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Linfoma de Células T Periférico / Depsipeptídeos / Inibidores de Histona Desacetilases / Antibióticos Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Linfoma de Células T Periférico / Depsipeptídeos / Inibidores de Histona Desacetilases / Antibióticos Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article